4.2 Article

Detection of actionable mutations in cytological specimens obtained by endoscopic ultrasound-guided fine needle aspiration with rapid onsite evaluation in pancreatic cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Side-by-side comparison of next-generation sequencing, cytology, and histology in diagnosing locally advanced pancreatic adenocarcinoma

Silvia Carrara et al.

Summary: This study demonstrated that tissue specimens obtained under EUS guidance allowed for DNA sample extraction and subsequent NGS analysis in 97% of cases, supporting the potential role of NGS as a complementary diagnostic test in PDAC diagnosis.

GASTROINTESTINAL ENDOSCOPY (2021)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Chemistry, Medicinal

Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor

Xiaolun Wang et al.

Summary: KRAS(G12D), the most common oncogenic KRAS mutation, is a promising target for solid tumor treatment. Selective inhibition of KRAS(G12C) presents a significant challenge due to the requirement of high affinity inhibitors to bind the mutant protein. The discovery of the noncovalent, potent, and selective KRAS(G12C) inhibitor MRTX1133, shown to be efficacious in a mouse tumor model, represents a significant advancement in the field.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Gastroenterology & Hepatology

Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients

Davide Melisi et al.

Summary: NGS analysis is valuable in detecting genomic alterations in PDC patients, especially after standard treatments failure, offering potential actionable mutations and molecularly targeted therapeutic approaches.

PANCREATOLOGY (2021)

Article Gastroenterology & Hepatology

Detection of actionable mutations in archived cytological bile specimens

Hiroshi Ohyama et al.

Summary: The study demonstrates that archived cytological specimens can be used to distinguish malignancy and detect drug-matched mutations in patients with advanced pancreaticobiliary cancer. Genomic profiling using ACS has an accuracy of 93%, sensitivity of 91%, and specificity of 100% in distinguishing between malignant and benign disorders. Actionable and drug-matched mutations were identified in 74% and 32% of ACS samples, respectively, highlighting the potential clinical implications of utilizing ACS for genomic profiling.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2021)

Editorial Material Oncology

Squamous Cell Carcinoma of the Lung With Micropapillary Pattern

Toshio Oyama et al.

JOURNAL OF THORACIC ONCOLOGY (2020)

Article Medicine, General & Internal

KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors

David S. Hong et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Biochemistry & Molecular Biology

Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study

Jason K. Sicklick et al.

NATURE MEDICINE (2019)

Article Oncology

Cancer statistics, 2019

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Article Biochemistry & Molecular Biology

COSMIC: the Catalogue Of Somatic Mutations In Cancer

John G. Tate et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Medicine, General & Internal

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

I. Ray-Coquard et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Multidisciplinary Sciences

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Dung T. Le et al.

SCIENCE (2017)

Article Multidisciplinary Sciences

Genomic analyses identify molecular subtypes of pancreatic cancer

Peter Bailey et al.

NATURE (2016)

Article Multidisciplinary Sciences

Whole genomes redefine the mutational landscape of pancreatic cancer

Nicola Waddell et al.

NATURE (2015)

Article Genetics & Heredity

Genomic spectra of biliary tract cancer

Hiromi Nakamura et al.

NATURE GENETICS (2015)

Article Medicine, General & Internal

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Medicine, General & Internal

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)